Early cranial ultrasound findings among infants with neonatal encephalopathy in Uganda: an observational study. by Tann, Cally J et al.
Official journal of the International Pediatric Research Foundation, Inc.
Articles Clinical Investigation nature publishing group
Background: In sub-Saharan Africa, the timing and nature 
of brain injury and their relation to mortality in neonatal 
encephalopathy (NE) are unknown. We evaluated cranial ultra-
sound (cUS) scans from term Ugandan infants with and with-
out NE for evidence of brain injury.
Methods: Infants were recruited from a national referral hos-
pital in Kampala. Cases (184) had NE and controls (100) were 
systematically selected unaffected term infants. All had cUS 
scans <36 h reported blind to NE status.
results: Scans were performed at median age 11.5 (inter-
quartile range (IQR): 5.2–20.2) and 8.4 (IQR: 3.6–13.5) hours, 
in cases and controls respectively. None had established 
antepartum injury. Major evolving injury was reported in 
21.2% of the cases vs. 1.0% controls (P < 0.001). White mat-
ter injury was not significantly associated with bacteremia 
in encephalopathic infants (odds ratios (OR): 3.06 (95% con-
fidence interval (CI): 0.98–9.60). Major cUS abnormality sig-
nificantly increased the risk of neonatal death (case fatality 
53.9% with brain injury vs. 25.9% without; OR: 3.34 (95% CI: 
1.61–6.95)).
conclusion: In this low-resource setting, there was no 
evidence of established antepartum insult, but a high propor-
tion of encephalopathic infants had evidence of major recent 
and evolving brain injury on early cUS imaging, suggesting 
prolonged or severe acute exposure to hypoxia–ischemia (HI). 
Early abnormalities were a significant predictor of death.
neonatal encephalopathy (NE) is a leading cause of neo-natal mortality and morbidity worldwide affecting more 
than one million infants around the world each year (1,2). 
There is a substantial body of evidence from high-income 
settings supporting an injury pattern on neuroimaging con-
sistent with hypoxia–ischemia (HI) that occurs in the imme-
diate perinatal period (3–5). However, the nature and timing 
of brain injury leading to NE in the term infant is poorly 
understood, particularly in low-income settings. NE may 
be considered a multifactorial disease involving a complex 
causal pathway with the contribution of individual risk fac-
tors likely to change according to their prevalence, frequency 
of exposure, care setting, and definition of NE used (6). 
In low-income countries, difficulties in accurate fetal moni-
toring and lack of standardized recording of intrapartum 
complications, mean that measures of intrapartum-related 
hypoxia, including cause and duration, are difficult to define 
(1). Delays in identification and referral of women experi-
encing obstetric and fetal complications may have important 
effects on the nature and timing of HI insults (7). Preclinical 
study findings suggest that newborn infection may sensitize 
the immature term brain to subsequent injury (8,9), a poten-
tially important factor in low-resource settings.
Understanding the nature, timing of onset, and duration 
of HI are key to evaluating which neuroprotective strategies 
may be effective (10). In high-income countries (HICs), mag-
netic resonance (MR) imaging, including diffusion-weighted 
imaging and MR spectroscopy, has been used to identify 
the nature and timing of insults and to predict neurodevel-
opmental outcome (4,11–13), however, MR imaging is not 
available in the majority of low-income countries. A decline 
in brain high energy phosphates seen on MR spectroscopy 
over the first 8–24 h after birth in babies with NE (14), a phe-
nomenon called secondary energy failure, has been observed 
to occur typically in parallel with the cascade of programmed 
cell death following a HI insult (15). In keeping with this 
evolving injury, abnormalities seen on cranial ultrasound 
(cUS) imaging, such as central gray matter, white matter, 
and cortical echodensities indicative of neuronal death, are 
frequently not evident on cUS or MR imaging until 24–48 h 
after HI (13,16).
The aims of this study were: (i) to evaluate cUS scans 
obtained soon after birth from term Ugandan infants with NE 
and unaffected term control infants for evidence of established 
and evolving brain injury, and (ii) to assess the contribution of 
perinatal infection to the pattern of brain injury.
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RESULTS
Study Participants
In total, early cUS was performed and assessed for 184 (87.6%) 
of 210 case infants. Among the 409 ABAaNA controls infants, 
105 infants were recruited sequentially from the start of the 
study as long as there was a study doctor available to perform 
the cUS. Of these, 69 were recruited from high-risk labor ward, 
and 36 recruited from the low-risk labor ward. After exclusion 
for poor image quality, 100 control infants remained (Figure 1). 
No significant differences were seen in baseline demographic 
and clinical characteristics between those with and without 
early scans, in either cohort (data not shown). Good-quality 
images from the second scan (day 4/5) were available for 88 
surviving infants with encephalopathy (Figure 1).
Baseline demographic and clinical characteristics of the 
cohorts are shown in Table 1. The majority of encephalopathic 
infants were moderately or severely affected (89.7%) (Table 1). 
A third of case infants died in the neonatal period and half had 
clinical seizures.
Comparison Between Cases and Controls
Median age at scanning was 11.5 h (interquartile range (IQR): 
5.2–20.2 h), and 8.4 h (IQR: 3.6–13.5 h) in cases and controls, 
respectively (P = 0.0019). The distribution of basal ganglia-
thalami (BGT) and white matter (WM) scores among case and 
control infants is shown in Table 2.
No abnormality was found in 45.1% (83/184) of cases and 
67.0% (67/100) controls (P < 0.001). Mild WM changes and 
mild/unilateral echogenicity in the BGT (score 1 and not 
indicative of major abnormality) were common among cases 
and controls. More case than control infants had mild WM 
changes (WM score 1, odds ratios (OR): 3.00 (95% confidence 
interval (CI): 1.46–6.15). There was no significant difference in 
mild BGT scores (BGT score 1, OR: 1.65 (95% CI: 0.96–2.85). 
One control had a score of 2 for BGT echogenicity (Table 2); 
this scan was reviewed postanalysis (by F.M.C.) and the score 
was considered marginal between 1 and 2 and the WM and 
cortex found normal. Score 3 for WM or BGT was uncommon 
(Table 2) among cases and absent among controls.
Overall, scans obtained within 36 h of birth showed a major 
abnormality in one fifth of encephalopathic infants (Table 3). 
When the analysis was restricted to scans obtained within 18 h 
of birth, the high case prevalence of major abnormalities per-
sisted (17.5%) (Table 3).
Pattern and Timing of Injury in NE
The pattern of injury seen among infants with NE is shown 
in Table 4. All major abnormalities (score ≥2) were of recent 
onset: no established injury with tissue atrophy, parenchymal 
cystic change, definite developmental abnormality, or large 
parenchymal hemorrhage was seen in either cases or controls. 
Subependymal pseudocysts, caudothalamic cysts, and choroid 
plexus cysts were common among all infants (12.5% (23/184) 
in cases vs. 17% (17/100) in controls).
Serial scans were performed on day 4/5 in 88 NE infants: 74 
had normal early scans, 35 (47.3%) becoming abnormal by day 
4/5. In the 14 with abnormal early cUS, 5 normalized and 9 
remained abnormal.
Neonatal Infection and Brain Injury
Among cases, bacteremia was detected in 20.0% (5/25) of 
infants with evidence of WM injury vs. 7.6% (12/159) of those 
without (OR: 3.06 (95% CI: 0.98–9.60) and in 18.2% (4/22) of 
cases with major BGT abnormality vs. 8.0% (13/162) of those 
without (OR: 2.55 (95% CI: 0.75–8.65)).
Neonatal Case Fatality
Among encephalopathic infants, a major abnormality seen on 
early cUS (<36 h) tripled the odds of neonatal death (case fatal-
ity with major abnormality 53.9% (21/39) vs. 25.9% (37/143) 
with no major abnormality (OR: 3.34 (95% CI: 1.61–6.95)). 
A similar pattern of association was seen for those scanned 
Figure 1. Flow diagram of study participants.
Encephalopathic term infants recruited to
ABAaNA study (cases)*
n = 210
Scanned with <36 h of birth
n = 184 (87.7%)
Scanned on day 4/5
n = 88
6 died prior to scanning
55 died day 0–3
30 discharged day 0–3
7 no doctor available to scan
7 images were poor quality
17 scanned >36 h after birth
3 excluded due to poor image quality
0 declined scanning
Non-encephalopathic term infants recruited to
ABAaNA study (controls)*
n = 105
Scanned within <36 h of birth
n = 100 (95.2%)
Scanned on day 4/5
n = 0
0 died
100 discharged prior to second scan
0 scanned >36 h after birth
0 died prior to scanning
5 excluded due to poor image quality
0 declined scanning
Volume 80  |  Number 2  |  August 2016      Pediatric RESEARCH 191
Official journal of the International Pediatric Research Foundation, Inc.
Articles         Tann et al.
within 18 h of birth (case fatality 59.1% (13/22) vs. 29.1% 
(30/103), respectively (OR: 3.51 (95% CI: 1.36–9.10)).
DISCUSSION
Our study showed a high prevalence of recent, evolving brain 
injury among encephalopathic infants on early cUS imag-
ing, in this low-resource Ugandan setting. Evidence of estab-
lished injury, indicative of an antepartum insult or congenital 
pathology, was not seen. Signs of major evolving injury, sugges-
tive of a relatively recent as opposed to an established antepar-
tum brain insult, affected one in five encephalopathic infants. 
In infants with encephalopathy, the presence of a major evolv-
ing brain injury tripled the likelihood of dying in the neonatal 
period. There was no significant increase in white matter injury 
seen among encephalopathic infants with neonatal infection.
Benefits of cUS are that it can be performed serially, at the 
bedside, and in the sickest of infants (17). It allows the early 
detection of congenital or another non-HI cause of NE and 
informs the timing of HI injury; as a consequence, it continues 
to be recommended as an important adjunct to MRI scanning 
for encephalopathic infants with NE in HICs (17,18). Previous 
studies from HICs have found abnormal cUS to be predic-
tive of outcome (3,17), with good correlation between MRI 
and cUS findings among infants with HIE in some, but not all 
 studies (3,19).
The cUS scoring system used by us successfully identified 
encephalopathic infants with major abnormalities on cUS, and 
differentiated between abnormalities suggestive of significant 
brain injury and other changes frequently seen among well 
term infants (20). Studies from HICs have shown unilateral 
BGT changes, equivalent to our score 1, to be associated with 
a more benign prognosis (3,21), suggesting that they are poor 
predictors of adverse neurodevelopmental outcome. This is 
likely to extend to our Ugandan population where focal uni-
lateral central gray matter changes and focal WM echogenicity 
were found to be common among well term Ugandan new-
borns (22).
This is the first study in a sub-Saharan low-income setting 
to use cUS to examine the nature and timing of newborn 
brain injury. A study from South India examined perina-
tal MRI findings among encephalopathic infants (23). That 
table 1. Baseline demographic and clinical characteristics of 
mothers and babies
Case N (%) Control N (%) P valueb
Maternal
  Maternal education 
  ≤ primary level
72/184 (39.1) 39/100 (39.0) 0.983
  Primiparity 112/184 (60.9) 48/100 (48.0) 0.037
  Emergency  
  cesarean section
43/183 (23.5) 16/100 (16.0) 0.138
Neonatal
  Male sex 116/184 (63.0) 51/100 (51.0) 0.049
  Mean birth  
   weight (g) (range)
3,196 (1,940–4,640) 3,065 (1,640–4,290) 0.023
  1-min Apgar <3 60/176 (34.1) 1/100 (1.0) <0.001
  5-min Apgar <7 118/162 (72.8) 1/100 (1.0) <0.001
Clinical features of encephalopathic infants
Grade of encephalopathya
  Mild 19/184 (10.3) -
  Moderate 105/184 (57.1) -
  Severe 60/184 (32.6) -
Absent suck 145/183 (79.2) -
Clinical seizures 100/184 (54.4) -
Comatose 48/184 (26.1) -
Neonatal case fatality 58/182 (31.9) -
aGrade encephalopathy defined according to Sarnat and Sarnat classification (18) on 
the worst day in the first 5 d after birth. bSignificance testing used chi-squared test 
except for mean birth weight where t-test for comparison of means was used.
table 2. Distribution of basal ganglia-thalami and white matter 
scores for case and controls
Cases (n = 184) n (%) Controls (n = 100) n (%)
BGT score
0 100 (54.4) 72 (72.0)
1 62 (33.7) 27 (27.0)
2 19 (10.3) 1 (1.0)
3 3 (1.6) 0 (0.0)
WM score
0 116 (63.0) 89 (89.0)
1 43 (23.4) 11 (11.0)
2 24 (13.0) 0 (0.0)
3 1 (0.5) 0 (0.0)
BGT, basal ganglia-thalami; WM, white matter.
table 3. Proportion of infants with major abnormalities on early cUS 
imaging
Age at imaging Case N (%) Control N (%) OR 95% CI
cUS performed <36 h 39/184 (21.2) 1/100 (1.0) 26.6 3.60–197.01
cUS perfomed <18 ha 22/126 (17.5) 1/85 (1.2) 17.77 2.35–134.56
aAnalysis restricted to infants scanned at <18 h of age. For this restricted analysis, 
median age at scanning was 7.8 h among cases (IQR: 4.0–11.9) and 7.1 h (IQR: 3.4–11.2) 
among controls, P = 0.210).
CI, confidence interval; cUS, cranial ultrasound; OR, odds ratio.
table 4. Pattern of major abnormality seen on early cUS among 
encephalopathic (case) infants (N = 184)
Major abnormalitya N (%)
No abnormality 145 (78.8%)
BGT abnormality 22 (12.0%)
WM abnormality 25 (13.6%)
Global abnormalityb 8 (4.4%)
aMajor abnormality in BGT or WM defined as a score of ≥2 in that area (injury seen in 
BGT and WM are not mutually exclusive). bGlobal abnormality was defined as a score ≥2 
in both the BGT and WM
BGT, basal ganglia-thalami; cUS, cranial ultrasound; WM, white matter
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study reported minimal antepartum established injury on 
MRI performed within 3 wk of birth. White matter injury 
was also common in this study (in 91%) and around a quar-
ter had deep gray matter injury (23). Comparison of our 
results with other cUS studies from HICs is hampered by 
differing definitions of NE used and inconsistency of brain 
abnormality definition. In the Netherlands, early changes on 
cUS (<6 h of age) were not found to be predictive of out-
come, with most infants with severe encephalopathy devel-
oping cUS abnormalities between 24–72 h of age (19). A 
good correlation was seen between later cUS abnormalities 
and  histological findings (16).
Defining the nature and timing of newborn brain injury in 
NE is key to understanding the most appropriate prevention 
and intervention strategies for NE. In this study, one in five 
encephalopathic infants had features of evolving brain injury 
on very early (median 11 h) scans. Since changes seen on cUS 
are recognized to take some time to develop after the original 
brain insult (19), this may imply that the injury pathway begins 
several hours before delivery, or a very severe acute exposure 
to HI. It is unclear whether severe injury may appear on cUS 
more rapidly than moderate injury; experimental studies show 
that secondary energy failure develops more rapidly in severe 
HI than moderate HI (24). The accelerated cell death cascade 
table 5. Scoring system used for basal ganglia and white matter abnormalities
Score Basal ganglia and thalami White matter
No abnormality 0 No abnormality No abnormality
Minor abnormality 1 Mild—swollen and/or small focal unilateral abnormality Mildly echogenic or patchy
Major abnormality 2 Clearly demarcated focal bilateral echogencity More diffuse and moderate/severe echogenicity
3 Bilateral, severe, extensive abnormalities Dense echogenicity and/or parenchymal cysts, atrophy, 
organizing hemorrhage
Figure 2. Normal basal ganglia and white matter seen on coronal (a, b) and parasagittal (c) images consistent with a score of 0.
a b c
Figure 3. Bilateral basal ganglia and thalamic echogenicity seen on coronal (a) and parasagittal (b) images consistent with a score of 2.
a b
Right Left
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may be reflected in earlier evidence of injury on cUS. As in 
South India, a high prevalence of WM injury was seen among 
cases on early imaging. This may be associated with perina-
tal infection and inflammation or may reflect other expo-
sures, including a less acute and more chronic HI insult. MRI 
diagnostic techniques could have contributed substantially to 
defining the nature and timing of brain injury (13,23,25), but 
unfortunately are not currently available in Uganda.
This study has limitations and challenges. First, all selection, 
interobserver and recall bias cannot be excluded completely. 
The case cohort is likely to have under-represented infants 
at either end of the spectrum of NE severity since the most 
severely affected often died prior to recruitment, and mildly 
affected infants may go undetected. Infants born on the low-
risk labor ward were slightly over-represented in the control 
group and cases were a median of 3 h older than controls when 
scanned. However, it seems unlikely that any of these factors 
contributed substantially to the large differences seen between 
case and control infants. Scans were read by two external 
experts blind to study status and all clinical and demographic 
data; so, minimizing observer bias but all inter- and intraob-
server bias cannot be excluded. Finally, since participants were 
recruited from a high-risk urban Ugandan referral centre, they 
may not reflect findings among infants from other, more rural 
populations.
Conclusions
In this study, in a Ugandan hospital setting, there was no 
cUS evidence of established antepartum injury, but a fifth of 
encephalopathic infants had evidence of major recent and 
evolving brain injury on early cUS imaging performed at a 
median age of 11 h. Since we assume from studies in HICs that 
it takes >24 h for injury to become apparent on cUS, this may 
suggest a brain insult occurring several hours before delivery 
or a very severe acute exposure to HI. These early abnormali-
ties were significant predictors of death in this population.
METHODS
This was a nested study of early brain imaging, conducted within a 
larger case-control study designed to investigate the etiology of NE in 
Figure 5. Severe dense echogenicity in the basal ganglia and thalami on parasagittal view (a) and global echogenicity and swelling in the white matter 
and cortex on coronal images (b) consistent with a score of 3.
a b
Figure 4. Diffuse, moderate/severe echogenicity in the white matter seen on coronal (a) and parasagittal (b) images consistent with a score of 2.
a b
Right
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Uganda (Associations between Birth Asphyxia and infections among 
Newborns in Africa—the “ABAaNA study”). Between 11 September 
2011 and 3 October 2012, 210 case and 409 control infants were 
recruited to the main study. The study was approved by the ethics 
committees of the London School of Hygiene and Tropical Medicine, 
Uganda Virus Research Institute and Mulago Hospital, and the 
Uganda National Council for Science and Technology
Setting
All infants were born and recruited at Mulago Hospital, a National 
Referral Hospital in Kampala, Uganda’s capital city. Over the 13-mo 
study period, 36,926 deliveries occurred at Mulago Hospital, 23% 
(8,767) by cesarean section. Women deliver on the low-risk or high-
risk labor ward (ratio 1:4). Fetal monitoring uses Pinard stethoscope 
for intermittent auscultation. Neonatal resuscitation, performed by 
attending midwives, includes oxygen and bag-mask ventilation. Sick 
newborns are transferred to the Special Care Unit. Piped oxygen and 
simple continuous positive airway pressure support are available, but 
not intubation and ventilation. Mothers care for well infants on the 
postnatal wards.
Study Participants
Participants were term infants <12 h of age with written parental 
informed consent, taken by trained study staff in the local language. 
NE case infants had a Thompson score of ≥6 (ref. (26)). Sarnat & 
Sarnat classification of encephalopathy severity (27) was assigned 
on the most severe day (between days 1–5). Contemporaneously 
recruited, unmatched controls (Thompson score ≤3) were system-
atically sampled from the labor ward admissions. For this cUS sub-
study, a comparison group of 100 control infants were eligible for 
inclusion. Information was collected from antenatal and hospital 
clinical records and structured maternal interviews in the local lan-
guage. Blood culture and species-specific bacterial real-time PCR 
assays detected neonatal bacteremia among all cases as previously 
described (28). Survival outcomes were recorded at 4 wk.
Cranial Ultrasound Scans
Scans were performed using a portable ultrasound machine (z.one 
ultra-Convertible Ultrasound System; Zonare Medical Systems, 
Mountain View, CA) with the P10-4 Phased Array Transducer (band-
width 4–10 MHz with tissue and compound harmonics of 8 Hx).
Study doctors (K.B., K.H.-J., N.N., F.N., A.T.) were trained to 
perform cUS by CT and FC using methods described previously 
(22,29,30), Minimally, five coronal, one midline sagittal and two 
parasagittal views on left and right were taken to visualize general 
anatomy, BGT, and WM. Scans were performed on recruitment (as 
soon as a trained study doctor was available) and again on day 4/5 in 
all surviving infants that remained in-patients. Images were down-
loaded, anonymized, and reported from DICOM-formatted images 
(OsiriX software, Geneva, Switzerland) by F.M.C. and C.H., blind to 
case/control status and all clinical data. Abnormalities were scored 
according to a system adapted from van Wezel-Meijler et al., (17) and 
used by us previously in Uganda (Table 5) (22).
As previous cUS studies in HICs suggest that changes on neuro-
imaging become evident >24 h after HI (13,16), only infants scanned 
for the first time within the first 36 h after birth were included. Our 
aim was to assess whether these scans appeared (i) normal (ii) had 
evidence of longstanding changes consistent with an antepartum 
insult or a developmental abnormality (parenchymal cysts, calcifi-
cation, atrophy, organizing hemorrhage) or (iii) evidence of a recent 
event, typical of acute or subacute HI injury (extensive echogenici-
ties in the BGT and WM). Signs of hemorrhage and focal arterial 
territory infarction were also looked for. Isolated cysts in the cho-
roid plexus, subependymal cysts, cysts in the caudo-thalamic notch, 
and lenticulostriate vasculopathy were not considered as major 
abnormalities (19).
Examples of image findings and their relationship to scores are 
shown in Figures 2–5. The presence of a “major abnormality” was 
defined as a score of 2 or 3 in either BGT, WM, or both. Cortex abnor-
malities were not graded as it was difficult to obtain systematic views 
on all infants and cortical abnormalities are seldom seen in isolation 
of BGT and WM changes.
Statistical Analysis
Analysis was performed using Stata version 11.0 (StataCorp, College 
Station, TX). Chi-squared test, t-test, and Wilcoxon rank sum test 
were used to compare proportions, means, and medians (where 
data was not normally distributed), respectively. Univariable logistic 
regression analysis was used to calculate OR and 95% CI. P < 0.05 
was taken as the formal level of statistical significance. Case fatality 
was defined as a death occurring in the neonatal period (0–28 d) as a 
proportion of infants at risk.
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